Skip to main content
. 2019 Jun 4;10:666. doi: 10.3389/fpls.2019.00666

Figure 3.

Figure 3

Lack of co-localization of VAPYRIN with markers for the vacuolar trafficking pathway and other subcellular compartments. (a) Co-expression of the late endosomal/prevacuolar marker mCherry-RabF2b with VAPYRIN-GFP reveals no co-localization. (b) Co-expression of the late endosomal/prevacuolar marker mCherry-RabF2a with VAPYRIN-GFP reveals no co-localization. (c) Co-expression of the late endosomal/prevacuolar marker mCherry-RabG3c with VAPYRIN-GFP reveals no co-localization. (d) Co-expression of the mitochondrial marker pIVD14s-eqFP611 with VAPYRIN-GFP reveals no co-localization. (e) Co-expression of the peroxisomal marker GFP(S65T)-APX(36) with VAPYRIN-RFP reveals no co-localization. (f) Co-expression of the plasma membrane marker PIP1;4-RFP with VAPYRIN-GFP reveals no co-localization. Size bar: 10 μm. See Figures S6, S7 for pictures of the separate channels.